US · Healthcare · Biotechnology
EPS came in at 0.11 against a street estimate of 0.06 — a beat of 83.3%.
with an average price target of $6.00.
| Fund | Stake |
|---|---|
| BlackRock Inc | 7.37% |
| American Century Companies Inc | 4.49% |
| Acadian Asset Management LLC | 3.98% |
| Renaissance Technologies Corp | 3.56% |
| Vanguard Capital Management, LLC | 3.56% |
| Vanguard Portfolio Management, LLC | 3.54% |
| LSV Asset Management | 3.13% |
| Dimensional Fund Advisors, Inc. | 2.94% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Puma Biotechnology Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.